HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 65.00
-0.60 (-0.91%)
Aug 12, 2025, 1:58 PM CST
Ligand Pharmaceuticals Revenue
In the year 2024, HeXun Biosciences had annual revenue of 286.42M TWD with 119.36% growth. HeXun Biosciences had revenue of 153.05M in the half year ending December 31, 2024, with 220.47% growth.
Revenue
286.42M
Revenue Growth
+119.36%
P/S Ratio
10.39
Revenue / Employee
6.36M
Employees
45
Market Cap
2.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 286.42M | 155.85M | 119.36% |
| Dec 31, 2023 | 130.57M | 81.10M | 163.95% |
| Dec 31, 2022 | 49.47M | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition